Skip to content
Health equity should not be considered a parallel initiative, but a central pillar of the biotech industry’s strategy, said experts on Day 3 of […]
BIO 2025: Health equity as an engine for scalable innovation Read More »
On Day 1 of the 2025 Biotechnology Innovation Organization (BIO) International Convention, a clear challenge was issued to the biotech industry: redefine how we understand,
BIO 2025: Let’s talk about sex (differences!) – specifically, women’s health Read More »
March 8th is International Women’s Day and to mark the occasion, Bio.News is exploring an under researched field of women’s health – autoimmune diseases
International Women’s Day: Improving women’s health by addressing autoimmune disease Read More »
Over 75% of clinical trial participants in the U.S. are white. This historical statistic has held true even today, even though the American population
The importance of caregivers in clinical trial diversity Read More »
“We are seeing an ongoing lack of participation by diverse groups in trials,” said Wayne Frederick, M.D., MBA, President Emeritus of Howard University and
How clinical trial diversity is the path to health equity Read More »
On November 19, the Biotechnology Innovation Organization (BIO) Clinical Trial Diversity Summit brought together a dynamic mix of researchers, industry leaders, policymakers, and community
BIO Clinical Trial Diversity Summit explores advancing equity in clinical research Read More »
As 2024 Pride Month concludes, the biotech industry reflects on the critical importance of LGBTQ+ representation and the ongoing efforts to foster inclusivity. The
Pride Month 2024: LGBTQ+ biotech leaders celebrate progress, recognize gaps Read More »
June 19 is a day of dual significance: World Sickle Cell Day and Juneteenth. It’s a day of celebration, acknowledging the remarkable progress in
World Sickle Cell Day 2024: A day to celebrate, a day to reflect Read More »
Biopharma supply chains, streamlining regulation, and other critical issues came up when the leader of the U.S. agency regulating drugs spoke with the leader
FDA’s Dr. Califf talks supply chains, clinical trial diversity, and America’s health Read More »
The Biotechnology Innovation Organization (BIO), in partnership with Korn Ferry, released the 2024 DEI report, Charting a Path to Inclusive Excellence for Biotechnology Companies,
Survey: DEI is good for business, but improvements are needed Read More »
